PRNewswire

MediLink and BioNTech collaborate on next-generation antibody-drug conjugate against HER3.

HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharmaceuticals are developing HL192 for Parkinson's Disease.

Midea RAC Thailand Factory celebrates millionth unit production and showcases innovative technology.

Metabolon launches Liver Fibrosis and Kidney Function Discovery Panels for researchers, providing insights into disease mechanisms and early detection.

China's Viomi Technology has announced actress Xiwei Tian as its brand spokesperson. The company aims to create healthy lifestyles through advanced technology, and the partnership with Tian will showcase its "hi-tech and fashionable" brand positioning. Viomi has developed an IoT @ Home platform consisting of smart home products and consumable items that allow consumers to interact with a range of IoT products to make daily life more convenient. Viomi's objective is to redefine the future home.

Phabuilder's Phamily initiative focuses on high-quality PHA materials research and collaboration.

WiMi Hologram Cloud announces data enhancement for convolutional neural networks (CNN) technology.

Akeso Inc. announced the publication of results for the clinical trial of cadonilimab. The trial marks the first use of PD-1/CTLA-4 dual immune checkpoint inhibitors for advanced solid tumors. Cadonilimab showed promising efficacy and safety as a monotherapy and in combination with chemotherapy. It received conditional approval in China and is being further investigated in ongoing clinical trials. The study was conducted by researchers from Peking University Cancer Hospital and Fudan University Shanghai Cancer Center.